Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0B4TT
|
|||
Former ID |
DCL000399
|
|||
Drug Name |
GSK1004723
|
|||
Synonyms |
CHEMBL1767168; SCHEMBL2819051
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Allergic rhinitis [ICD-11: CA08.0] | Discontinued in Phase 1 | [1] | |
Company |
GSK
|
|||
Structure |
Download2D MOL |
|||
Formula |
C39H49ClN4O2
|
|||
Canonical SMILES |
C1CCCN(CC1)CCCOC2=CC=C(C=C2)CCCCN3CCCC3CN4C(=O)C5=CC=CC=C5C(=N4)CC6=CC=C(C=C6)Cl
|
|||
InChI |
1S/C39H49ClN4O2/c40-33-19-15-32(16-20-33)29-38-36-13-3-4-14-37(36)39(45)44(41-38)30-34-12-9-27-43(34)26-8-5-11-31-17-21-35(22-18-31)46-28-10-25-42-23-6-1-2-7-24-42/h3-4,13-22,34H,1-2,5-12,23-30H2/t34-/m1/s1
|
|||
InChIKey |
YANGEESWIGIKOP-UUWRZZSWSA-N
|
|||
CAS Number |
CAS 955359-72-5
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Histamine H1 receptor (H1R) | Target Info | Antagonist | [2] |
Histamine H3 receptor (H3R) | Target Info | Antagonist | [2] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Calcium signaling pathway | ||||
Inflammatory mediator regulation of TRP channels | ||||
Panther Pathway | Histamine H1 receptor mediated signaling pathway | |||
Reactome | Histamine receptors | |||
G alpha (i) signalling events | ||||
G alpha (q) signalling events | ||||
WikiPathways | Monoamine Transport | |||
GPCRs, Class A Rhodopsin-like | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
Monoamine GPCRs | ||||
IL-4 Signaling Pathway | ||||
Gastrin-CREB signalling pathway via PKC and MAPK |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028155) | |||
REF 2 | Clinical pipeline report, company report or official report of GlaxoSmithKline (2009). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.